Loading…
Underlying
Underlying Price
$38.90
Type
Put
Strike
45
Expiration
Sep 17, 2027
DTE
328d
Moneyness
ITM
Intrinsic
$6.10
NVO 45 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $8.08 | +4.94% | 3 | 0 |
| Oct 30, 2026 | 6d | $7.45 | +15.86% | 30 | 0 |
| Nov 6, 2026 | 13d | $5.25 | -20.09% | 1 | 10 |
| Nov 13, 2026 | 20d | $5.50 | -19.12% | 1 | 3 |
| Nov 20, 2026 | 27d | $5.55 | -6.72% | 12 | 10,848 |
| Nov 27, 2026 | 34d | — | — | 0 | 0 |
| Dec 18, 2026 | 55d | $5.81 | -6.89% | 22 | 11,097 |
| Jan 15, 2027 | 83d | $6.09 | -5.58% | 24 | 10,734 |
| Mar 19, 2027 | 146d | $6.70 | -6.29% | 10 | 3,229 |
| Jun 17, 2027 | 236d | $8.15 | -5.78% | 6 | 7,577 |
| Sep 17, 2027 | 328d | $8.77 | -4.47% | 2 | 269 |
| Dec 17, 2027 | 419d | $8.98 | -2.71% | 1 | 3,153 |
| Jan 21, 2028 | 454d | $9.80 | +3.38% | 2 | 6,443 |
| Jun 16, 2028 | 601d | $11.20 | +5.56% | 1 | 361 |
| Dec 15, 2028 | 783d | $10.75 | -0.83% | 2 | 1,050 |
| Jan 19, 2029 | 818d | $10.67 | -2.11% | 1 | 44 |
NVO Nearby Strikes · Sep 17, 2027
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 30 P | $1.63 | -7.91% | 5 | 3,937 | OTM |
| 32.5 P | $2.74 | -10.16% | 1 | 770 | OTM |
| 35 P | $3.05 | -4.39% | 4 | 1,837 | OTM |
| 37.5 P | $4.15 | -2.35% | 23 | 2,057 | OTM |
| 40 P | $5.35 | -3.60% | 1 | 4,074 | ITM |
| 42.5 P | $6.85 | -4.46% | 1 | 732 | ITM |
| 45 P | $8.77 | -4.47% | 2 | 269 | ITM |
| 47.5 P | $10.60 | -8.07% | 1 | 83 | ITM |
| 50 P | $12.51 | -5.87% | 2 | 126 | ITM |
| 52.5 P | $14.40 | +21.01% | 2 | 25 | ITM |
| 55 P | $16.48 | -6.20% | 2 | 390 | ITM |
| 60 P | $23.18 | +7.81% | 1 | 311 | ITM |
| 65 P | $27.88 | +0.29% | 5 | 37 | ITM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.